Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole

Izchak Kohen1, Paula E Lester2, Sum Lam31Division of Geriatric Psychiatry, Zucker-Hillside Hospital, Glen Oaks, NY, USA; 2Division of Geriatric Medicine, Winthrop University Hospital, Mineola, NY, USA; 3Division of Pharmacy and Geriatrics, St. John’s University College of Pharmacy and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Izchak Kohen, Paula E Lester, Sum Lam
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://doaj.org/article/1e895516365f4bd180c20bd790210b76
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1e895516365f4bd180c20bd790210b76
record_format dspace
spelling oai:doaj.org-article:1e895516365f4bd180c20bd790210b762021-12-02T07:57:30ZAntipsychotic treatments for the elderly: efficacy and safety of aripiprazole1176-63281178-2021https://doaj.org/article/1e895516365f4bd180c20bd790210b762010-03-01T00:00:00Zhttp://www.dovepress.com/antipsychotic-treatments-for-the-elderly-efficacy-and-safety-of-aripip-a4023https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021Izchak Kohen1, Paula E Lester2, Sum Lam31Division of Geriatric Psychiatry, Zucker-Hillside Hospital, Glen Oaks, NY, USA; 2Division of Geriatric Medicine, Winthrop University Hospital, Mineola, NY, USA; 3Division of Pharmacy and Geriatrics, St. John’s University College of Pharmacy and Allied Health Professions, Queens, NY, USAAbstract: Delusions, hallucinations and other psychotic symptoms can accompany a number of conditions in late life. As such, elderly patients are commonly prescribed antipsychotic medications for the treatment of psychosis in both acute and chronic conditions. Those conditions include schizophrenia, bipolar disorder, depression and dementia. Elderly patients are at an increased risk of adverse events from antipsychotic medications because of age-related pharmacodynamic and pharmacokinetic changes as well as polypharmacy. Drug selection should be individualized to the patient’s previous history of antipsychotic use, current medical conditions, potential drug interactions, and potential side effects of the antipsychotic. Specifically, metabolic side effects should be closely monitored in this population. This paper provides a review of aripiprazole, a newer second generation antipsychotic agent, for its use in a variety of psychiatric disorders in the elderly including schizophrenia, bipolar disorder, dementia, Parkinson’s disease and depression. We will review the pharmacokinetics and pharmacodynamics of aripiprazole as well as dosing, diagnostic indications, efficacy studies, and tolerability including its metabolic profile. We will also detail patient focused perspectives including quality of life, patient satisfaction and adherence.Keywords: aripiprazole, antipsychotics, elderly, adverse drug reaction Izchak KohenPaula E LesterSum LamDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2010, Iss Issue 1, Pp 47-58 (2010)
institution DOAJ
collection DOAJ
language EN
topic Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Izchak Kohen
Paula E Lester
Sum Lam
Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole
description Izchak Kohen1, Paula E Lester2, Sum Lam31Division of Geriatric Psychiatry, Zucker-Hillside Hospital, Glen Oaks, NY, USA; 2Division of Geriatric Medicine, Winthrop University Hospital, Mineola, NY, USA; 3Division of Pharmacy and Geriatrics, St. John’s University College of Pharmacy and Allied Health Professions, Queens, NY, USAAbstract: Delusions, hallucinations and other psychotic symptoms can accompany a number of conditions in late life. As such, elderly patients are commonly prescribed antipsychotic medications for the treatment of psychosis in both acute and chronic conditions. Those conditions include schizophrenia, bipolar disorder, depression and dementia. Elderly patients are at an increased risk of adverse events from antipsychotic medications because of age-related pharmacodynamic and pharmacokinetic changes as well as polypharmacy. Drug selection should be individualized to the patient’s previous history of antipsychotic use, current medical conditions, potential drug interactions, and potential side effects of the antipsychotic. Specifically, metabolic side effects should be closely monitored in this population. This paper provides a review of aripiprazole, a newer second generation antipsychotic agent, for its use in a variety of psychiatric disorders in the elderly including schizophrenia, bipolar disorder, dementia, Parkinson’s disease and depression. We will review the pharmacokinetics and pharmacodynamics of aripiprazole as well as dosing, diagnostic indications, efficacy studies, and tolerability including its metabolic profile. We will also detail patient focused perspectives including quality of life, patient satisfaction and adherence.Keywords: aripiprazole, antipsychotics, elderly, adverse drug reaction
format article
author Izchak Kohen
Paula E Lester
Sum Lam
author_facet Izchak Kohen
Paula E Lester
Sum Lam
author_sort Izchak Kohen
title Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole
title_short Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole
title_full Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole
title_fullStr Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole
title_full_unstemmed Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole
title_sort antipsychotic treatments for the elderly: efficacy and safety of aripiprazole
publisher Dove Medical Press
publishDate 2010
url https://doaj.org/article/1e895516365f4bd180c20bd790210b76
work_keys_str_mv AT izchakkohen antipsychotictreatmentsfortheelderlyefficacyandsafetyofaripiprazole
AT paulaelester antipsychotictreatmentsfortheelderlyefficacyandsafetyofaripiprazole
AT sumlam antipsychotictreatmentsfortheelderlyefficacyandsafetyofaripiprazole
_version_ 1718399026915704832